Forecast & Rating2 analysts currently cover Protalix Biotherap, of which 1 give a positive rating. The average price target is $11.00, about 299.3% upside from the current price of $2.76. Coverage is limited, so the data is for reference only. Data as of Sep 9, 2026; this does not constitute investment advice.
Sep 9, 2026Price forecast
$11.00299.27%
Forecast & RatingStrong buy
1analysts
- Strong buy100.00%
- Buy0.00%
- Hold0.00%
- Sell0.00%
- Strong sell0.00%
Target price forecast
Forecast dateSep 21, 2026
Forecast met0.0%
Stock price$2.76
Avg. target$11.0
High target$12
Low target$10
Analyst ratings
Strong buy
Buy
Hold
Sell
Strong sell
Source: S&P Global
This information is for reference only and is not investment advice.